Eli Lilly Accused Of Paying Bribes To Chinese Doctors

Eli Lilly & Company is facing charges by a whistle blower of paying bribes to doctors in China to prescribe the pharmaceutical company's drugs. Reuters is reporting that a former senior manager for the company claims that bribery and illegal payments at Lilly's Chinese operations were widespread. The report says Lilly is the third pharmaceutical company to face similar accusations in China. Lilly told Reuters it is "deeply concerned" about the allegations. "Although we have not been able to verify these allegations, we take them seriously, and we are continuing our investigation," a statement from the company read. Lilly paid a $29 million fine to the SEC last year to settle a charge that it had bribed government officials in Russia, China, Brazil and Poland to win business.